Cambios en la expresión de proteínas apoptóticas en retina de ratas diabéticas inducidas con estreptozotocina
Contenido principal del artículo
Resumen
Determinar la expresión de proteínas apoptóticas en retina de ratas diabéticas inducidas con estreptozotocina mediante citometría de flujo e inmunohistoquímica.
Detalles del artículo
Sección
Cómo citar
Referencias
The Expert Committee on The diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
McBean AM, Li S, Gilbertson DT, et al. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: Whites, Blacks, Hispanics and Asians. Diabetes Care 2004; 27: 2317-24.
Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005; 28: S37-S42.
Standards of Medical Care in Diabetes. Diabetes Care 2005; 28: S4-S36.
Roy MS, Klein R, O'Colmain BJ, et al. The prevalence of diabetic retinopathy among adult type 1 diabetic person in the United States. Arch Ophthalmology 2004; 122: 546-51.
West SK, Klein R, Rodríguez J, et al. Diabetes and diabetic retinopathy in a Mexican American population. Diabetes Care 2004; 24: 1204-9.
American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, Calif. American Academy of Ophthalmology; 2004.
Frank RN. On the pathogenesis of diabetic retinopathy. A 1990 update. Ophthalmology 1991; 98: 586-93.
Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996; 98: 2018-26.
Hammers HP, Lin J, Bretzel RG, Brownlee M, Breier G. Up regulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998; 47: 401-6.
Cai J, Wu M, Nelson KC. Oxidant-Induced apoptosis in cultured human retinal pigment epithelial cells. Invest Oph Vis Sci 1999; 40: 959-66.
Hinton DR, He S, Lopez PF. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol 1998; 116: 203-9.
Barreiro R, Schadlu R, Rendón J, et al. The role of Fas-Fas-L in the development and treatment of ischquemic retinopathy. Inv Oph Vis Sci 1998; 44: 1282-6.
Joussen AM, Poulaki V, Mitsiades N, et al. Suppression of FasFasLinduced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocininduced diabetes. The FASEB Journal 2003; 17: 76-8.
Aiello LP. Vascular Endothelial Growth Factor, 20th-Century Mechanisms, 21st-Century Therapies. Inv Oph Vis Sci 1997; 38(9):
-52.
Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic Retinopathy. Diabetes Care 2004; 27: 2540-3.
Nyberg P, Xie L, Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res 2005; 65(10): 3967-79.
Jiang S, Wu MW, Sternberg P, Jones P. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells. Inv Oph Vis Sci
; 41: 645-55.
Morff RJ. Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozotocin induced diabetes. Diabetes 1999; 39: 354.